Novartis NVS will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Novartis to report an earnings per share (EPS) of $2.08.
The market awaits Novartis's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past Earnings
The company's EPS beat by $0.19 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at Novartis's past performance and the resulting price change:
Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
EPS Estimate | 1.79 | 1.96 | 1.86 | 1.69 |
EPS Actual | 1.98 | 2.06 | 1.97 | 1.80 |
Price Change % | -0.0% | -1.0% | -1.0% | 1.0% |
Novartis Share Price Analysis
Shares of Novartis were trading at $112.14 as of April 25. Over the last 52-week period, shares are up 15.69%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Novartis visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.